Clinical Trials For frontotemporal dementia To Start By 2013


Clinical Trials For frontotemporal dementia To Start By 2013

A neurodegenerative disease, frontotemporal dementia starts with silence and damages personality traits and then affects the brain. It gets very late for doctors to address the problem and till the time they get to know about, a person suffering from it, is left with very less time.

The disease was first discovered some 100 years back, but then also researchers have not been able to find probable reasons as well as treatment of the problem. It has also been found those maximum survival years of person after diagnosis of disease is not more than eight years.

However, researchers at the University of California have identified drugs that can treat the rare neurodegenerative problem. It is said that the study researchers are going to initiate clinical trials for the same by 2013.

Dr. Bruce L. Miller, who is a Professor of neurology and psychiatry in University of California, said that it is high time that researchers should know that there are different subtypes of dementia. "I think at least some subtypes of frontotemporal dementia will be the first neurodegenerative diseases we find a cure for", said Miller.

Miller further said that there are chances that the development helps understanding Alzheimer's disease in a better way.

Latest News

Clean Energy Research to get Historic Investment during the United Nations
Investors Keenly Wait for OPEC Meeting; Oil Prices Move Up a Little
Amazon Testing Drones in Multiple International Locations
NextEra Agrees to Sell Two Texas Power Plants to Luminant
China’s Yuan Could be Named a Reserve Currency by the IMF
Rupert Murdoch Tweets Tribune Probably Selling Los Angeles Times
Black Friday Shopping “Uninspiring” in Brick and Mortar Stores; Shopping Trends
U.S. Crude Drops Further Due to Surplus Supply
CVC and CPPIB Outbid Others for a Possible Deal to Buy Petco for $4.7 Billion
US Government All Set to Introduce a New Law for Americans “Seriously Delinquent
Reportedly Pfizer Plans to Acquire Allergan in a Deal of $150 Billion or More
In October Most States Experienced a Drop in Unemployment Rate